BioCentury
ARTICLE | Clinical News

Leica Bond Oracle HER2 IHC System regulatory update

April 30, 2012 7:00 AM UTC

FDA approved a PMA from Leica's Leica Biosystems division for Leica Bond Oracle HER2 IHC System to determine HER2 oncoprotein status in formalin-fixed, paraffin-embedded breast cancer tissue. The immu...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article